Call to arrange a consultation
+1 416 777 0888

Pfizer Canada Inc. v. Mayne Pharma (Canada) Inc.

Represented Mayne Pharma (Canada) Inc. in a proceeding under the Patented Medicines (Notice of Compliance) Regulations relating to Pfizer’s Camptosar (irinotecan) product. The decision is reported at 2005 FCA 396.

Meet the team